Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjune Sen

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Neurology|August 8, 2020
Development and validation of a predictive model of drug-resistant genetic generalized epilepsyHyunmi Choi, Kamil Detyniecki, Carl Bazil, et al.
Epilepsy & Behavior Reports|March 4, 2026
CORE-VNS: Dosing and titration of VNS therapy in contemporary clinical practiceRyan Verner, Francesca Beraldi, Michal Tzadok, et al.
Bjpsych Open|November 7, 2024
Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkit - CORRIGENDUMTom Shillito, Lance Watkins, Hafsha Ali, et al.
The Lancet. Digital Health|March 24, 2023
Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control studyGabriel Davis Jones, Symon M Kariuki, Anthony K Ngugi, et al.
Bjpsych Open|October 28, 2024
Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkitTom Shillito, Lance Watkins, Hafsha Ali, et al.
Epilepsy & Behavior : E&B|May 18, 2025
"The traditional healer said, 'I had a genie that scared me in my eyes, and that is why I fall": An ethnographic study in Mahenge, TanzaniaPendo F Magili, Isolide S Massawe, Vivian P Mushi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinSarah K Tate, Chantal Depondt, Sanjay M Sisodiya, et al.
Annals of Clinical and Translational Neurology|July 16, 2024
Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug-resistant epilepsyWenzheng Xiong, Tianrong Yeo, Jeanne Tan May May, et al.
Epilepsy & Behavior : E&B|August 29, 2025
Levetiracetam in epilepsy and autism spectrum disorder: analysis of safety, tolerability, and efficacyJon Allard, William Henley, Brendan McLean, et al.
Plos One|January 17, 2025
Translation, adaptation and validation of an epilepsy screening instrument in two Ghanaian languagesEmmanuel Kwame Darkwa, Sabina Asiamah, Elizabeth Awini, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Neurology|August 8, 2020
Development and validation of a predictive model of drug-resistant genetic generalized epilepsyHyunmi Choi, Kamil Detyniecki, Carl Bazil, et al.
Epilepsy & Behavior Reports|March 4, 2026
CORE-VNS: Dosing and titration of VNS therapy in contemporary clinical practiceRyan Verner, Francesca Beraldi, Michal Tzadok, et al.
Bjpsych Open|November 7, 2024
Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkit - CORRIGENDUMTom Shillito, Lance Watkins, Hafsha Ali, et al.
The Lancet. Digital Health|March 24, 2023
Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control studyGabriel Davis Jones, Symon M Kariuki, Anthony K Ngugi, et al.
Bjpsych Open|October 28, 2024
Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkitTom Shillito, Lance Watkins, Hafsha Ali, et al.
Epilepsy & Behavior : E&B|May 18, 2025
"The traditional healer said, 'I had a genie that scared me in my eyes, and that is why I fall": An ethnographic study in Mahenge, TanzaniaPendo F Magili, Isolide S Massawe, Vivian P Mushi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinSarah K Tate, Chantal Depondt, Sanjay M Sisodiya, et al.
Annals of Clinical and Translational Neurology|July 16, 2024
Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug-resistant epilepsyWenzheng Xiong, Tianrong Yeo, Jeanne Tan May May, et al.
Epilepsy & Behavior : E&B|August 29, 2025
Levetiracetam in epilepsy and autism spectrum disorder: analysis of safety, tolerability, and efficacyJon Allard, William Henley, Brendan McLean, et al.
Plos One|January 17, 2025
Translation, adaptation and validation of an epilepsy screening instrument in two Ghanaian languagesEmmanuel Kwame Darkwa, Sabina Asiamah, Elizabeth Awini, et al.
Pageof 13